West Bancorporation’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,465
Closed -$393K 102
2024
Q3
$393K Buy
3,465
+60
+2% +$7.13K 0.26% 52
2024
Q2
$422K Sell
3,405
-220
-6% -$28.3K 0.31% 46
2024
Q1
$478K Buy
3,625
+14
+0.4% +$1.73K 0.31% 46
2023
Q4
$394K Sell
3,611
-916
-20% -$95.1K 0.25% 60
2023
Q3
$466K Sell
4,527
-5,699
-56% -$614K 0.33% 50
2023
Q2
$1.18M Sell
10,226
-319
-3% -$36.2K 0.79% 27
2023
Q1
$1.12M Sell
10,545
-602
-5% -$65K 0.85% 26
2022
Q4
$1.24M Sell
11,147
-497
-4% -$50.8K 0.92% 27
2022
Q3
$1M Sell
11,644
-939
-7% -$83.8K 0.74% 28
2022
Q2
$1.15M Buy
12,583
+4,863
+63% +$431K 0.81% 23
2022
Q1
$633K Buy
7,720
+1,152
+18% +$90.8K 0.39% 45
2021
Q4
$503K Buy
+6,568
New +$523K 0.4% 35
2020
Q3
$583K Sell
7,367
-105
-1% -$8.22K 0.68% 24
2020
Q2
$551K Buy
7,472
+126
+2% +$9.48K 0.64% 26
2020
Q1
$539K Sell
7,346
-100
-1% -$7.86K 0.75% 26
2019
Q4
$646K Buy
+7,446
New +$612K 0.65% 27

Other funds holding MRK

West Bancorporation's MRK Position: Q4 2024 in Review

West Bancorporation sold out of Merck (MRK) in Q4 2024, closing a stake of 3,465 shares — an estimated $393K sold.

West Bancorporation first reported a position in MRK in Q4 2019 and held it in 16 quarters. The position peaked at $1.24M in Q4 2022. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • West Bancorporation reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • West Bancorporation sold 3,465 Merck shares in Q4 2024, an estimated $393K.
  • West Bancorporation first reported a position in Merck in Q4 2019 and held it in 16 quarters.
  • West Bancorporation's Merck position peaked at $1.24M in Q4 2022.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on West Bancorporation's 13F filing for Q4 2024, filed 23 Jan 2025.